Tech Company Financing Transactions

Alimera Sciences Funding Round

Alimera Sciences closed a $15.9 million Series B funding round on 11/28/2006. Investors included Domain Associates, Intersouth Partners and Polaris Partners.

Transaction Overview

Company Name
Alimera Sciences
Announced On
11/28/2006
Transaction Type
Venture Equity
Amount
$15,900,000
Round
Series B
Investors

Domain Associates (Brian Halak)

Intersouth Partners (Philip Tracy)

Polaris Partners (Bryce Youngren)

Scale Venture Partners (Mark Brooks)

Venrock (Anders Hove)

Proceeds Purpose
The additional resources will be used to further develop Medidur�, Alimera Sciences' Phase III-stage treatment for diabetic macular edema (DME). The company will also use these funds to expand its development pipeline-- including additional drug delivery technologies that have been identified-- and to capitalize on other strategic opportunities as they arise.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6120 Windward Pkwy. 290
Alpharetta, GA 30005
USA
Phone
(678) 990-5740
Website
www.alimerasciences.com
Email Address
[email protected]
Overview
Biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals with a focus on the back of the eye, or retina.
Profile
Alimera Sciences LinkedIn Company Profile
Social Media
Alimera Sciences Company Twitter Account
Company News
Alimera Sciences News
Facebook
Alimera Sciences on Facebook
YouTube
Alimera Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Eiswirth
  Rick Eiswirth LinkedIn Profile  Rick Eiswirth Twitter Account  Rick Eiswirth News  Rick Eiswirth on Facebook
Chief Financial Officer
Philip Jones
  Philip Jones LinkedIn Profile  Philip Jones Twitter Account  Philip Jones News  Philip Jones on Facebook
Chief Medical Officer
Samer Kaba
  Samer Kaba LinkedIn Profile  Samer Kaba Twitter Account  Samer Kaba News  Samer Kaba on Facebook
Chief Operating Officer
Philip Ashman
  Philip Ashman LinkedIn Profile  Philip Ashman Twitter Account  Philip Ashman News  Philip Ashman on Facebook
VP - Marketing
Dave Holland
  Dave Holland LinkedIn Profile  Dave Holland Twitter Account  Dave Holland News  Dave Holland on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/28/2006: Where Are You Now venture capital transaction
Next: 11/28/2006: Augmentix venture capital transaction

 

Share this article

 

Where The Data Comes From

We record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.